The results showed that EC-targeted delivery of miR-218 significantly downregulated MYC expression, accompanied by repressed TEC proliferation (Figure 6F-G, S7C-D), although tumor growth was not obviously changed (Figure S7A-B). This evidence concerns the gene MYC and neoplasm.